A study published by The BMJ finds a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought.
A damning report published by the Public Accounts Committee says that “NHS Test and Trace has not achieved its main objective to help break chains of COVID-19 transmission and enable people to return towards a more normal way of life”.
In a new study, researchers from University of Copenhagen present what could be a much-needed helping hand to fight COVID-19.
Testing operations by the Immensa Health Clinic, Wolverhampton, have been suspended following an investigation into reports of people receiving negative PCR test results after they have previously tested positive on a Lateral Flow Device (LFD).
Vaccine clinical trial participants are to be offered the option to get additional vaccine doses from next week.
A new study has revealed important insights into the natural human antiviral defences against SARS-CoV-2, the virus that causes COVID-19.
The University of Kent’s School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified a protein that may critically contribute to severe forms of COVID-19.
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the Government confirmed it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%, according to results announced by AstraZeneca who developed the antibody known as AZD7442.
A new clinical trial will investigate whether a third dose of vaccine for people with weakened immune systems gives a stronger immune response than two doses.
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency.